HYTACAND Side Effects

6440075-1 | Hyponatraemia, Loss Of Consciousness, Malaise
on Nov 05, 2009 Female patient from FRANCE , 78 years of age, was diagnosed with hypertension and was treated with Hytacand (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, loss of consciousness, malaise. Hytacand dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREVISCAN (5 Days/7 Days) (View Previscan Review and Previscan Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

6434055-X | Fall, Hypotension, Loss Of Consciousness, Traumatic Brain Injury
Patient was taking Hytacand (View Usage). Patient had the following side effects: fall (What is fall?), hypotension, loss of consciousness, traumatic brain injury (What is traumatic brain injury?) on Nov 02, 2009 from FRANCE Additional patient health information: Female patient , 79 years of age, . Hytacand dosage: . Patient was hospitalized.

6264790-8 | Neutropenia
Adverse event was reported on Jul 01, 2009 by a Female patient taking Hytacand (View Usage) (Dosage: 16+12.5 Mg 1.5 Tablets/day) was diagnosed with hypertension and. Location: FRANCE , 57 years of age, After Hytacand was administered, patient had the following side effects: neutropenia. During the same period patient was treated with TENORDATE (View Tenordate Review and Tenordate Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), TEMESTA (View Temesta Review and Temesta Label ), EFFERALGAN CODEINE (View Efferalgan Codeine Review and Efferalgan Codeine Label ).

6234287-X | Renal Failure Chronic
on Jun 10, 2009 Female patient from FRANCE , weighting 136.7 lb, was diagnosed with hypertrophic cardiomyopathy, hypertension, arteritis obliterans, dyslipidaemia, dizziness (What is dizziness?), osteoarthritis (What is osteoarthritis?) and was treated with Hytacand (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure chronic. Hytacand dosage: Tablet 16 + 12.5 Mg. During the same period patient was treated with CELECTOL (View Celectol Review and Celectol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), VASTAREL (View Vastarel Review and Vastarel Label ), STRUCTUM (View Structum Review and Structum Label ), TEMESTA (View Temesta Review and Temesta Label ), PROPOFAN (View Propofan Review and Propofan Label ).


6142643-3 | Blood Pressure Decreased, Intentional Overdose, Suicide Attempt
on Mar 27, 2009 Female patient from FRANCE , 48 years of age, was treated with Hytacand (View Usage). Patient had the following side effects: blood pressure decreased, intentional overdose, suicide attempt. Hytacand dosage: 480 + 375 Mg. Patient was hospitalized.

5872490-9 | Pemphigoid, Pruritus
Patient was taking Hytacand (View Usage). After Hytacand was administered, patient had the following side effects: pemphigoid, pruritus on Sep 01, 2008 from FRANCE Additional patient health information: Female patient , 70 years of age, . Hytacand dosage: . During the same period patient was treated with LERCAN (View Lercan Review and Lercan Label ). Patient was hospitalized.

5845502-6 | Pemphigoid
Adverse event was reported on Aug 13, 2008 by a Female patient taking Hytacand (View Usage) (Dosage: ) . Location: FRANCE , 70 years of age, Patient experienced the following unwanted or unexpected effects: pemphigoid. During the same period patient was treated with LERCAN (View Lercan Review and Lercan Label ). Patient was hospitalized.

5842297-7 | Pemphigoid
on Aug 07, 2008 Female patient from FRANCE , 70 years of age, was treated with Hytacand (View Usage). Patient had the following side effects: pemphigoid. Hytacand dosage: . During the same period patient was treated with LERCAN (View Lercan Review and Lercan Label ). Patient was hospitalized.

5600219-8 | Hyponatraemia
on Jan 14, 2008 Female patient from FRANCE , 85 years of age, weighting 154.3 lb, was diagnosed with hypertension, epilepsy (What is epilepsy?), depression (What is depression?), anxiety (What is anxiety?) and was treated with Hytacand (View Usage). After Hytacand was administered, patient had the following side effects: hyponatraemia. Hytacand dosage: 8 + 12.5 Mg Daily. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), PROZAC (View Prozac Review and Prozac Label ), LASIX (View Lasix Review and Lasix Label ), DOGMATIL (View Dogmatil Review and Dogmatil Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

5593343-X | Renal Impairment
Patient was taking Hytacand (View Usage). Patient experienced the following unwanted or unexpected effects: renal impairment on Jan 08, 2008 from FRANCE Additional patient health information: Male patient , weighting 156.5 lb, . Hytacand dosage: 16 + 12.5 Mg Daily. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), LERCAN (View Lercan Review and Lercan Label ), PLAVIX (View Plavix Review and Plavix Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

5488303-3 | Hyponatraemia, Loss Of Consciousness, Malaise, Orthostatic Hypotension
Adverse event was reported on Oct 10, 2007 by a Female patient taking Hytacand (View Usage) (Dosage: ) was diagnosed with hypertension, parkinson's disease (What is parkinson's disease?) and. Location: FRANCE , weighting 141.1 lb, Patient had the following side effects: hyponatraemia, loss of consciousness, malaise, orthostatic hypotension. During the same period patient was treated with SECTRAL (View Sectral Review and Sectral Label ), MODOPAR (400 + 100 Mg Daily) (View Modopar Review and Modopar Label ), LIPANOR (View Lipanor Review and Lipanor Label ). Patient was hospitalized.

5479781-4 | Circulatory Collapse, Pruritus, Rash
on Oct 01, 2007 Female patient from FRANCE , 85 years of age, was treated with Hytacand (View Usage). After Hytacand was administered, patient had the following side effects: circulatory collapse, pruritus, rash (What is rash?). Hytacand dosage: 16 + 12.5 Mg Daily. Patient was hospitalized.

5350986-6 | Hypoglycaemia, Malaise, Orthostatic Hypotension
on Jun 01, 2007 Male patient from FRANCE , 70 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with Hytacand (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, malaise, orthostatic hypotension. Hytacand dosage: 16 + 12.5 Mg Daily. During the same period patient was treated with UMULINE NPH (View Umuline Nph Review and Umuline Nph Label ), UMULINE RAPIDE (View Umuline Rapide Review and Umuline Rapide Label ), PREVISCAN (View Previscan Review and Previscan Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

5231249-6 | Bundle Branch Block Left, Cardiac Failure
Patient was taking Hytacand (View Usage). Patient had the following side effects: bundle branch block left, cardiac failure on Jan 30, 2007 from FRANCE Additional patient health information: Male patient , 67 years of age, weighting 286.6 lb, . Hytacand dosage: . During the same period patient was treated with DIOSMIN (View Diosmin Review and Diosmin Label ), INIPOMP (View Inipomp Review and Inipomp Label ), AVANDAMET (View Avandamet Review and Avandamet Label ), ALFUZOSIN HYDROCHLORIDE (View Alfuzosin Hydrochloride Review and Alfuzosin Hydrochloride Label ). Patient was hospitalized.

5213071-X | Nervous System Disorder
Adverse event was reported on Jan 09, 2007 by a Female patient taking Hytacand (View Usage) (Dosage: ) . Location: FRANCE , 60 years of age, After Hytacand was administered, patient had the following side effects: nervous system disorder. During the same period patient was treated with TERALITHE (View Teralithe Review and Teralithe Label ). Patient was hospitalized.

5211925-1 | Cryptogenic Organising Pneumonia, Respiratory Failure, Weight Decreased
on Jan 09, 2007 Male patient from FRANCE , 77 years of age, was diagnosed with hypertension, supraventricular extrasystoles and was treated with Hytacand (View Usage). Patient experienced the following unwanted or unexpected effects: cryptogenic organising pneumonia, respiratory failure, weight decreased. Hytacand dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), VASTEN (View Vasten Review and Vasten Label ), TEMESTA (View Temesta Review and Temesta Label ). Patient was hospitalized.

5146244-5 | Hypoglycaemia, Malaise, Orthostatic Hypotension
on Oct 30, 2006 Male patient from FRANCE , 70 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with Hytacand (View Usage). Patient had the following side effects: hypoglycaemia, malaise, orthostatic hypotension. Hytacand dosage: 16 + 12.5 Mg Daily. During the same period patient was treated with UMULINE NPH (View Umuline Nph Review and Umuline Nph Label ), UMULINE RAPIDE (View Umuline Rapide Review and Umuline Rapide Label ), PREVISCAN (View Previscan Review and Previscan Label ), TOPALGIC (View Topalgic Review and Topalgic Label ). Patient was hospitalized.

5096334-0 | Acute Myocardial Infarction, Atrial Fibrillation, Blood Calcium Decreased, Bundle Branch Block Right, Diabetes Mellitus, Electrocardiogram Repolarisation Abnormality, Fall, Femoral Neck Fracture
Patient was taking Hytacand (View Usage). After Hytacand was administered, patient had the following side effects: acute myocardial infarction, atrial fibrillation (What is atrial fibrillation?), blood calcium decreased, bundle branch block right, diabetes mellitus, electrocardiogram repolarisation abnormality, fall (What is fall?), femoral neck fracture on Jul 03, 2006 from FRANCE Additional patient health information: Male patient , 78 years of age, weighting 154.3 lb, . Hytacand dosage: 16 + 12.5 Mg Once Daily. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CREON (View Creon Review and Creon Label ), INSULIN (View Insulin Review and Insulin Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

5069647-6 | Loss Of Consciousness, Malaise
Adverse event was reported on Jul 24, 2006 by a Female patient taking Hytacand (View Usage) (Dosage: 16 + 12.5 Mg Once Daily) was diagnosed with essential hypertension, musculoskeletal pain, atrial fibrillation (What is atrial fibrillation?), atrial flutter and. Location: FRANCE , 86 years of age, Patient experienced the following unwanted or unexpected effects: loss of consciousness, malaise. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), PREVISCAN (View Previscan Review and Previscan Label ), PHYSIOTENS (View Physiotens Review and Physiotens Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), TEMESTA (View Temesta Review and Temesta Label ), NOCTAMIDE (View Noctamide Review and Noctamide Label ). Patient was hospitalized.

5064461-X | Blood Pressure Decreased, Blood Pressure Increased, Heart Rate Irregular, Loss Of Consciousness, Malaise
on Jul 24, 2006 Female patient from FRANCE , 86 years of age, was diagnosed with essential hypertension, musculoskeletal pain, atrial fibrillation (What is atrial fibrillation?), atrial flutter and was treated with Hytacand (View Usage). Patient had the following side effects: blood pressure decreased, blood pressure increased, heart rate irregular, loss of consciousness, malaise. Hytacand dosage: 16 + 12.5 Mg Once Daily. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), PREVISCAN (View Previscan Review and Previscan Label ), PHYSIOTENS (View Physiotens Review and Physiotens Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), TEMESTA (View Temesta Review and Temesta Label ), NOCTAMIDE (View Noctamide Review and Noctamide Label ). Patient was hospitalized.

5064460-8 | Fall, Hyperkalaemia, Renal Failure
on Jul 03, 2006 Male patient from FRANCE , 78 years of age, weighting 154.3 lb, was treated with Hytacand (View Usage). After Hytacand was administered, patient had the following side effects: fall (What is fall?), hyperkalaemia, renal failure. Hytacand dosage: 16 + 12.5 Mg Daily. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CREON (View Creon Review and Creon Label ), INSULIN (View Insulin Review and Insulin Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

5049294-2 | Hyperkalaemia
Patient was taking Hytacand (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia on Jul 03, 2006 from FRANCE Additional patient health information: Male patient , 78 years of age, weighting 154.3 lb, . Hytacand dosage: 16 + 12.5 Mg Daily. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CREON (View Creon Review and Creon Label ), INSULIN (View Insulin Review and Insulin Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

5022169-0 | Dizziness, Dysphonia, Hiccups, Nausea, Pharyngitis, Pharyngolaryngeal Pain, Tonsillar Hypertrophy
Adverse event was reported on Jun 07, 2006 by a Male patient taking Hytacand (View Usage) (Dosage: ) . Location: FRANCE , 80 years of age, Patient had the following side effects: dizziness (What is dizziness?), dysphonia, hiccups, nausea (What is nausea?), pharyngitis, pharyngolaryngeal pain, tonsillar hypertrophy. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), MONICOR LP (View Monicor Lp Review and Monicor Lp Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLOR (View Amlor Review and Amlor Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5000986-0 | Blood Pressure Decreased, Dizziness, Loss Of Consciousness, Malaise
on Apr 06, 2006 Male patient from FRANCE , 76 years of age, weighting 152.1 lb, was treated with Hytacand (View Usage). After Hytacand was administered, patient had the following side effects: blood pressure decreased, dizziness (What is dizziness?), loss of consciousness, malaise. Hytacand dosage: . During the same period patient was treated with CELECTOL (View Celectol Review and Celectol Label ), DEBRIDAT (View Debridat Review and Debridat Label ), LASILIX (View Lasilix Review and Lasilix Label ), MEDIATOR (View Mediator Review and Mediator Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), OGAST (View Ogast Review and Ogast Label ). Patient was hospitalized.

4968780-4 | Dizziness, Hypotension, Loss Of Consciousness, Malaise
on Apr 06, 2006 Male patient from FRANCE , 76 years of age, weighting 152.1 lb, was treated with Hytacand (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypotension, loss of consciousness, malaise. Hytacand dosage: . During the same period patient was treated with CELECTOL (View Celectol Review and Celectol Label ), DEBRIDAT (View Debridat Review and Debridat Label ), LASILIX (View Lasilix Review and Lasilix Label ), MEDIATOR (View Mediator Review and Mediator Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), OGAST (View Ogast Review and Ogast Label ). Patient was hospitalized.

4951600-1 | Atrioventricular Block First Degree, Bradypnoea, Coma, Respiratory Distress
Patient was taking Hytacand (View Usage). Patient had the following side effects: atrioventricular block first degree, bradypnoea, coma, respiratory distress on Mar 14, 2006 from FRANCE Additional patient health information: Female patient , 85 years of age, weighting 165.3 lb, . Hytacand dosage: . During the same period patient was treated with ISOPTIN (View Isoptin Review and Isoptin Label ), COVERSYL (View Coversyl Review and Coversyl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

4803479-6 | Confusional State, Fall, Hallucination, Hallucinations, Mixed, Head Injury, Hyponatraemia
Adverse event was reported on Oct 10, 2005 by a Female patient taking Hytacand (View Usage) (Dosage: ) was diagnosed with essential hypertension, angina pectoris and. Location: FRANCE , 90 years of age, After Hytacand was administered, patient had the following side effects: confusional state, fall (What is fall?), hallucination, hallucinations, mixed, head injury, hyponatraemia. During the same period patient was treated with MONICOR LP (View Monicor Lp Review and Monicor Lp Label ), CELIPROLOL (View Celiprolol Review and Celiprolol Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

4724793-9 | Amnesia, Diarrhoea, Face Injury, Loss Of Consciousness, Malaise, Orthostatic Hypotension
on Jul 18, 2005 Male patient from FRANCE , 68 years of age, was diagnosed with hypertension and was treated with Hytacand (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, diarrhoea, face injury, loss of consciousness, malaise, orthostatic hypotension. Hytacand dosage: 16 + 12.5 Mg Qd. During the same period patient was treated with EUPRESSYL (View Eupressyl Review and Eupressyl Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), SOPROL (View Soprol Review and Soprol Label ), NOOTROPYL (View Nootropyl Review and Nootropyl Label ), BIPERIDYS (View Biperidys Review and Biperidys Label ), METFORMIN (View Metformin Review and Metformin Label ), LIPIREX (View Lipirex Review and Lipirex Label ), AVANDIA (View Avandia Review and Avandia Label ). Patient was hospitalized.

4719976-8 | Confusional State, Malaise, Speech Disorder
on Jul 12, 2005 Female patient from FRANCE , 78 years of age, was diagnosed with hypertension and was treated with Hytacand (View Usage). Patient had the following side effects: confusional state, malaise, speech disorder. Hytacand dosage: 16 + 12.5 Mg Qd. During the same period patient was treated with LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ). Patient was hospitalized.

4623456-8 | Fall, Humerus Fracture, Malaise, Orthostatic Hypotension, Rib Fracture
Patient was taking Hytacand (View Usage). After Hytacand was administered, patient had the following side effects: fall (What is fall?), humerus fracture, malaise, orthostatic hypotension, rib fracture on Mar 21, 2005 from Additional patient health information: Female patient , 89 years of age, was diagnosed with essential hypertension and. Hytacand dosage: 0.5 Df Qd Po. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PLAVIX (View Plavix Review and Plavix Label ), TEMESTA (View Temesta Review and Temesta Label ), VASTAREL (View Vastarel Review and Vastarel Label ). Patient was hospitalized.

4621144-5 | Renal Failure Acute
Adverse event was reported on Mar 14, 2005 by a Female patient taking Hytacand (View Usage) (Dosage: 1 Df Daily Po) was diagnosed with essential hypertension, back pain (What is back pain?) and. Location: , 76 years of age, weighting 202.8 lb, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with FUROSEMIDE (1 Df Daily Po) (View Furosemide Review and Furosemide Label ), FLODIL SLOW RELEASE (View Flodil - Slow Release Review and Flodil - Slow Release Label ), CORDARONE (View Cordarone Review and Cordarone Label ), PREVISCAN (View Previscan Review and Previscan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TROXERUTINE (View Troxerutine Review and Troxerutine Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

4551830-7 | Peripheral Sensory Neuropathy
on Jan 03, 2005 Female patient from , 75 years of age, was diagnosed with essential hypertension and was treated with Hytacand (View Usage). Patient had the following side effects: peripheral sensory neuropathy. Hytacand dosage: 1 Df Qd Po. During the same period patient was treated with CAPTOPRIL (50 Mg Bid Po) (View Captopril Review and Captopril Label ). Patient was hospitalized.